Hypoglycemic and hypolipidemic effects of a novel dual peroxisome proliferator-activated receptor (PPAR) alpha/gamma agonist, E3030, in db/db mice

被引：0
|
作者：
Inoue, T
Yoshitomi, H
Kasai, S
Hihara, T
Matsuura, F
Shinoda, M
Saeki, T
Tanaka, I
机构：
来源：
DIABETES | 2004年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A129 / A129
页数：1
相关论文
共 50 条
  • [1] Antidiabetic and hypolipidemic effects of a novel dual peroxisome proliferator-activated receptor (PPAR) α/γ agonist, e3030, in db/db mice and beagle dogs
    Kasai, Shunji
    Inoue, Takashi
    Yoshitomi, Hideki
    Hihara, Taro
    Matsuura, Fumiyoshi
    Harada, Hitoshi
    Shinoda, Masanobu
    Tanaka, Isao
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2008, 108 (01) : 40 - 48
  • [2] Hypolipidemic effects of a novel dual PPARα/γ agonist, E3030, in beagle dogs
    Kasai, S
    Inoue, T
    Yoshitomi, H
    Hihara, T
    Matsuura, F
    Shinoda, M
    Saeki, T
    Tanaka, I
    DIABETES, 2004, 53 : A131 - A131
  • [3] Peroxisome proliferator-activated receptor α/γ dual agonist tesaglitazar attenuates diabetic nephropathy in db/db mice
    Cha, Dae Ryong
    Zhang, Xiaoyan
    Zhang, Yahua
    Wu, Jing
    Su, Dongming
    Han, Jee Young
    Fang, Xuefen
    Yu, Bo
    Breyer, Matthew D.
    Guan, Youfei
    DIABETES, 2007, 56 (08) : 2036 - 2045
  • [4] The dual peroxisome proliferator-activated receptor alpha/delta agonist GFT505 exerts anti-diabetic effects in db/db mice without peroxisome proliferator-activated receptor gamma-associated adverse cardiac effects
    Hanf, Remy
    Millatt, Lesley J.
    Cariou, Bertrand
    Noel, Benoit
    Rigou, Geraldine
    Delataille, Philippe
    Daix, Valerie
    Hum, Dean W.
    Staels, Bart
    DIABETES & VASCULAR DISEASE RESEARCH, 2014, 11 (06): : 440 - 447
  • [5] A nonthiazolidinedione peroxisome proliferator-activated receptor γ agonist reverses endothelial dysfunction in diabetic (db/db-/-) mice
    Howarth, AG
    Wiehler, WB
    Pannirselvam, M
    Jiang, YF
    Berger, JP
    Severson, D
    Anderson, TJ
    Triggle, CR
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 316 (01): : 364 - 370
  • [6] The dual peroxisome proliferator-activated receptor α/γ activator muraglitazar prevents the natural progression of diabetes in db/db mice
    Tozzo, Effie
    Ponticiello, Randolph
    Swartz, JoAnn
    Farrelly, Dennis
    Zebo, Rachel
    Welzel, Gustav
    Egan, Donald
    Kunselman, Lori
    Peters, Andrew
    Gu, Liqun
    French, Michele
    Chen, Sean
    Devasthale, Pratik
    Janovitz, Evan
    Staal, Ada
    Harrity, Thomas
    Belder, Rene
    Cheng, Peter T.
    Whaley, Jean
    Taylor, Simeon
    Hariharan, Narayanan
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 321 (01): : 107 - 115
  • [7] A Nonthiazolidinedione Peroxisome Proliferator-Activated Receptor α/γ Dual Agonist CG301360 Alleviates Insulin Resistance and Lipid Dysregulation in db/db Mice
    Jeong, Hyun Woo
    Lee, Joo-Won
    Kim, Woo Sik
    Choe, Sung Sik
    Shin, Hyun Jung
    Lee, Gha Young
    Shin, Dongkyu
    Lee, Jun Hee
    Choi, Eun Bok
    Lee, Hyun Kyu
    Yon, Gyu Hwan
    Cho, Bongjun
    Kim, Hye Ryung
    Choi, Sung Hee
    Chung, Young Sun
    Park, Seung Bum
    Chung, Heekyoung
    Ro, Seonggu
    Kim, Jae Bum
    MOLECULAR PHARMACOLOGY, 2010, 78 (05) : 877 - 885
  • [8] Peroxisome proliferator-activated receptor (PPAR)-alpha/gamma agonism enhances arteriogenesis in mice
    Werner, C.
    Schirmer, S. H.
    Boehm, M.
    Laufs, U.
    EUROPEAN HEART JOURNAL, 2014, 35 : 1122 - 1123
  • [9] Hypolipidemic effects of silymarin are not mediated by the peroxisome proliferator-activated receptor alpha
    Orolin, J.
    Vecera, R.
    Jung, D.
    Meyer, U. A.
    Skottova, N.
    Anzenbacher, P.
    XENOBIOTICA, 2007, 37 (07) : 725 - 735
  • [10] Balaglitazone: A Second Generation Peroxisome Proliferator-Activated Receptor (PPAR) Gamma (γ) Agonist
    Agrawal, R.
    Jain, P.
    Dikshit, S. N.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2012, 12 (02) : 87 - 97
12345